Earth Science Tech (OTCMKTS:ETST) versus Jazz Pharmaceuticals (NASDAQ:JAZZ) Critical Comparison

Earth Science Tech (OTCMKTS:ETST) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.

Risk & Volatility

Earth Science Tech has a beta of 2.53, suggesting that its share price is 153% more volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Institutional and Insider Ownership

95.7% of Jazz Pharmaceuticals shares are owned by institutional investors. 4.6% of Jazz Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.


This table compares Earth Science Tech and Jazz Pharmaceuticals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Earth Science Tech -1,750.31% N/A -2,929.76%
Jazz Pharmaceuticals 7.86% 20.16% 10.85%

Earnings and Valuation

This table compares Earth Science Tech and Jazz Pharmaceuticals’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Earth Science Tech $530,000.00 3.55 -$1.20 million N/A N/A
Jazz Pharmaceuticals $2.16 billion 4.22 $523.37 million $14.60 10.97

Jazz Pharmaceuticals has higher revenue and earnings than Earth Science Tech.

Analyst Recommendations

This is a breakdown of recent ratings for Earth Science Tech and Jazz Pharmaceuticals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Earth Science Tech 0 0 0 0 N/A
Jazz Pharmaceuticals 1 1 17 0 2.84

Jazz Pharmaceuticals has a consensus target price of $187.37, indicating a potential upside of 16.96%. Given Jazz Pharmaceuticals’ higher probable upside, analysts plainly believe Jazz Pharmaceuticals is more favorable than Earth Science Tech.


Jazz Pharmaceuticals beats Earth Science Tech on 10 of the 11 factors compared between the two stocks.

About Earth Science Tech

Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, and aging. Its products include vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. It also offers Cannabidiol oil to retailers in the vaping industry; and cannabinoid products. In addition, the company retails health, wellness, sports nutrition, and dietary supplement products. Earth Science Tech, Inc. offers its products through its retail store located in Coral Gables, Florida, as well as through the internet. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Doral, Florida.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Receive News & Ratings for Earth Science Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Earth Science Tech and related companies with's FREE daily email newsletter.